Ortiz-Pérez, E., Moreno-Rodríguez, A., Delgado-Maldonado, T., Ortega-Balleza, J. L., González-González, A., Paz-González, A. D., . . . Rivera, G. Repositioning FDA-Approved Sulfonamide-Based Drugs as Potential Carbonic Anhydrase Inhibitors in <i>Trypanosoma cruzi</i>: Virtual Screening and In Vitro Studies. MDPI AG.
Chicago Style (17th ed.) CitationOrtiz-Pérez, Eyra, et al. Repositioning FDA-Approved Sulfonamide-Based Drugs as Potential Carbonic Anhydrase Inhibitors in <i>Trypanosoma Cruzi</i>: Virtual Screening and In Vitro Studies. MDPI AG.
MLA (9th ed.) CitationOrtiz-Pérez, Eyra, et al. Repositioning FDA-Approved Sulfonamide-Based Drugs as Potential Carbonic Anhydrase Inhibitors in <i>Trypanosoma Cruzi</i>: Virtual Screening and In Vitro Studies. MDPI AG.
Warning: These citations may not always be 100% accurate.